Rheumatology
Takayasu Arteritis | JACC Focus Seminar
14 Feb, 2023 | 10:39h | UTCTakayasu Arteritis: JACC Focus Seminar 3/4 – Journal of the American College of Cardiology
Related:
Retrospective Study | Outcomes of percutaneous intervention in patients with Takayasu arteritis
14 Feb, 2023 | 10:38h | UTCRelated:
Takayasu Arteritis: JACC Focus Seminar 3/4 – Journal of the American College of Cardiology
Position Paper | Diagnosis, prevention and treatment of common shoulder injuries in sport
10 Feb, 2023 | 14:01h | UTC
Commentary on Twitter
Common shoulder injuries ? – grading the evidence on: ?
? Diagnosis – included 19 clinical tests
✋ Prevention – injury prevention programmes
?️♂️ Treatment – stretching, ice packs, strengthening, compressionStatement paper commissioned by DSSF
➡️ https://t.co/CN7usTd3HR pic.twitter.com/xavDN5MICY
— British Journal of Sports Medicine (BJSM) (@BJSM_BMJ) January 16, 2023
RCT | Efficacy and safety of bimekizumab in axial spondyloarthritis
10 Feb, 2023 | 13:42h | UTCRelated:
Bimekizumab versus Secukinumab in Plaque Psoriasis – New England Journal of Medicine
Bimekizumab versus Adalimumab in Plaque Psoriasis – New England Journal of Medicine
RCT | Genicular nerve block vs. intra-articular triamcinolone in juvenile idiopathic arthritis
10 Feb, 2023 | 13:36h | UTC
Review | Pyoderma gangrenosum: Established and emerging pharmacological treatments
8 Feb, 2023 | 12:27h | UTC
SR | Calcium and vitamin D supplements do not increase bone mineral density or prevent fractures in premenopausal women
7 Feb, 2023 | 14:18h | UTCCalcium and vitamin D for increasing bone mineral density in premenopausal women – Cochrane Library
Summary: Calcium and vitamin D for improving bone health in healthy premenopausal women – Cochrane Library
Cohort Study | Autoimmune diseases and new-onset atrial fibrillation
3 Feb, 2023 | 13:52h | UTCAutoimmune diseases and new-onset atrial fibrillation: a UK Biobank study – EP Europace
Review | Perioperative evaluation and management of patients on glucocorticoids
2 Feb, 2023 | 14:35h | UTCRelated: Perioperative Evaluation and Management of Endocrine Disorders – Mayo Clinic Proceedings
M-A | Comparative efficacy of exercise therapy and oral NSAIDs and paracetamol for knee or hip osteoarthritis
1 Feb, 2023 | 13:28h | UTC
Commentary on Twitter
Network meta-analysis of 152 RCTs (17431 pts) comparing efficacy of exercise therapy, NSAIDs, Tylenol for knee or hip osteoarthritis: Found all 3 equivalent at 4 wk, 8 wk and 24 wks. https://t.co/rKck2AacL4 pic.twitter.com/YEAMh9UxTs
— Dr. John Cush (@RheumNow) January 10, 2023
Recommendations for the management of incidental musculoskeletal findings on MRI and CT
31 Jan, 2023 | 14:08h | UTC
Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population
30 Jan, 2023 | 00:51h | UTCEstimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population – JAMA (free for a limited period)
Commentaries:
Study provides an estimate of people in the United States with VEXAS syndrome – News Medical
Prevalence of VEXAS Syndrome Identified in U.S. Health System – HealthDay
M-A | Metabolic adverse events associated with systemic corticosteroid therapy
24 Jan, 2023 | 14:10h | UTC
Health and economic outcomes associated with musculoskeletal disorders attributable to high BMI in 192 countries
23 Jan, 2023 | 13:16h | UTC
RCT | Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to TNFα inhibitors
19 Jan, 2023 | 14:05h | UTC
Cohort Study | Hydroxychloroquine dose and risk for incident retinopathy
18 Jan, 2023 | 14:21h | UTCHydroxychloroquine Dose and Risk for Incident Retinopathy: A Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – American College of Physicians
Commentary: Long-term low-dose hydroxychloroquine use associated with low risk for retinopathy – ACP Internist
RCT | Efficacy and safety of Risankizumab for active psoriatic arthritis
18 Jan, 2023 | 14:04h | UTCCommentary: Risankizumab Safe, Effective at 52 Weeks for Psoriatic Arthritis – HealthDay
Phase 2 RCT | No benefit from the Bruton’s tyrosine kinase inhibitor Evobrutinib in systemic lupus erythematosus
12 Jan, 2023 | 12:54h | UTC
Atypical ulcers: a stepwise approach for clinicians
10 Jan, 2023 | 14:00h | UTCAtypical Ulcers: A Stepwise Approach for Clinicians – Wounds
ACP Guideline | Pharmacologic treatment of primary osteoporosis or low bone mass to prevent fractures in adults
9 Jan, 2023 | 14:59h | UTCSummary for Patients: Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults
2022 ACR/EULAR classification criteria for giant cell arteritis.
16 Dec, 2022 | 13:39h | UTCNews Release: Updated: GCA Classification Criteria – European Alliance of Associations for Rheumatology
RCT | Effect of diet and exercise on knee pain in patients with osteoarthritis and overweight or obesity.
16 Dec, 2022 | 13:36h | UTCEffect of Diet and Exercise on Knee Pain in Patients With Osteoarthritis and Overweight or Obesity: A Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
Pictorial Review | Nerve entrapment syndromes of the upper limb.
15 Dec, 2022 | 13:25h | UTCNerve entrapment syndromes of the upper limb: a pictorial review – Insights into Imaging
SR | Use of acupuncture for adult health conditions, 2013 to 2021.
14 Dec, 2022 | 14:54h | UTC
2022 ACR/EULAR classification criteria for Takayasu arteritis.
12 Dec, 2022 | 12:50h | UTCNews Release: Classification criteria established for Takayasu arteritis – European Alliance of Associations for Rheumatology, EULAR